Summary Slide.png (34.02 kB)

Lifetime Cost-Utility Analyses of Deferasirox in Beta-Thalassaemia Patients with Chronic Iron Overload

Download (34.02 kB)
figure
posted on 27.02.2018 by Jonathan Karnon, Keith Tolley, Joao Vieira, David Chandiwana
The full text can be found at:

https://link.springer.com/article/10.1007/s40261-012-0008-2

Funding

Novartis Pharmaceuticals

History

Licence

Exports

Logo branding

Licence

Exports